Glycomacropeptide Formula With Docosahexaenoic Acid And Low Phenylalanine
Recommended MetabolicRestrictedNot applicable line
Dietary management of phenylketonuria (PKU).
1
Submissions
1 resub
2019–19
On the record
—
ICER range
Cost-min
Cost basis
Decisions on record
- Meeting Mar 2026 Recommended Phenylketonuria (PKU)
- Meeting Mar 2024 Withdrawn Phenylketonuria (PKU) no PSD
Access path
- Jul 2019Recommended
vs PKU Glytactin RTD 10
- PBS listing · Restricted
RecommendedDeferredNot recommended
From the public summary
PBAC outcome
6.1 The PBAC agreed with the listing of the glycomacropeptide formula, PKU GMPro® LQ, for the dietary management of phenylketonuria (PKU) processed by the Secretariat.PSD · Jul 2019
The PBAC advised that the pricing of the previously recommended powder and new liquid formulations should be set at the same cost per gram of protein equivalent (PE).PSD · Jul 2019
Consumer comments
4.2 The PBAC noted there were no consumer comments received for this item. Comparison with similar productsPSD · Jul 2019
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated by design.
The PBAC noted it had recommended the powder formulation of PKU GMPro on a cost minimisation basis with PKU Glytactin RTD 10 at the same cost per gram of PE. PBAC · 2019
Cost-effectiveness accepted
Decision context
PopulationPatients with phenylketonuria (PKU) requiring dietary management via oral liquid glycomacropeptide formula.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2019 | Recommended | PKU Glytactin RTD 10 | — | Cost-minimisation · Cost-minimisation |
Similar precedents
Glycomacropeptide Formula With Docosahexaenoic Acid With Low Phenylalanine96%Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low In Phenylalanine93%Glycomacropeptide Formula With Amino Acids, Vitamins, Minerals, Trace Elements, Carbohydrate, Fat And Low Phenylalanine88%Glycomacropeptide Formula With Amino Acids And Low Phenylalanine87%Glycomacropeptide And Essential Amino Acids With Vitamins And Minerals84%Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low Phenylalanine85%Glycomacropeptide And Essential Amino Acids84%Amino Acid Formula Without Phenylalanine80%
Regulatory · TGA
Label narrower than PBS population — PBAC restricts to patients requiring oral liquid glycomacropeptide formula; TGA label permits any dietary management approach.